Quantitative real-time PCR: a powerful ally in cancer research.

[1]  R. Herrmann,et al.  DCR3 locus is a predictive marker for 5‐fluorouracil‐based adjuvant chemotherapy in colorectal cancer , 2002, International journal of cancer.

[2]  R. Herrmann,et al.  SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer , 2002, British Journal of Cancer.

[3]  P. S. Eis,et al.  Invader technology for DNA and RNA analysis: principles and applications , 2002, Expert review of molecular diagnostics.

[4]  M. Gonzales,et al.  Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients. , 2002, Journal of immunological methods.

[5]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[6]  A. Hart,et al.  Detection of circulating breast tumor cells by differential expression of marker genes. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  P. Campochiaro.  Gene therapy for retinal and choroidal diseases , 2002, Expert opinion on biological therapy.

[8]  F. Marincola,et al.  The role of quantitative PCR for the immune monitoring of cancer patients , 2002, Expert opinion on biological therapy.

[9]  Dieter Klein,et al.  Quantification using real-time PCR technology : applications and limitations , 2002 .

[10]  D. Ginzinger.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. , 2002, Experimental hematology.

[11]  A. Elkahloun,et al.  In Situ Gene Expression Analysis of Cancer Using Laser Capture Microdissection, Microarrays and Real Time Quantitative PCR , 2002, Cancer biology & therapy.

[12]  C. N. Gundry,et al.  Real-time multiplex PCR assays. , 2001, Methods.

[13]  V. Didenko,et al.  DNA probes using fluorescence resonance energy transfer (FRET): designs and applications. , 2001, BioTechniques.

[14]  K. Miller,et al.  Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction. , 2001, Urology.

[15]  A. Kalbe,et al.  Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  R. Lea,et al.  Beta-actin--an unsuitable internal control for RT-PCR. , 2001, Molecular and cellular probes.

[17]  S. Bustin,et al.  Expression of HLA Class II in Colorectal Cancer: Evidence for Enhanced Immunogenicity of Microsatellite-Instability-Positive Tumours , 2001, Tumor Biology.

[18]  F. Marincola,et al.  Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination , 2001, The Journal of Immunology.

[19]  O. Berthier‐Vergnes,et al.  Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. , 2001, Analytical biochemistry.

[20]  F. Marincola,et al.  Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness , 2001, International journal of cancer.

[21]  C. Barthe,et al.  Expression of interferon-alpha (IFN-alpha) receptor 2c at diagnosis is associated with cytogenetic response in IFN-alpha-treated chronic myeloid leukemia. , 2001, Blood.

[22]  M. Caligiuri,et al.  Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  F. Marincola,et al.  Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization , 2001, The Journal of Immunology.

[24]  H. Höfler,et al.  Tissue microdissection techniques in quantitative genome and gene expression analyses , 2001, Histochemistry and Cell Biology.

[25]  Fude Fang,et al.  Fudenine, a C-terminal truncated rat homologue of mouse prominin, is blood glucose-regulated and can up-regulate the expression of GAPDH. , 2001, Biochemical and biophysical research communications.

[26]  C. Eckert,et al.  Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction. , 2001, Cancer research.

[27]  A. Sober,et al.  A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. , 2001, Archives of dermatology.

[28]  A. Pileri,et al.  A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. , 2001, Experimental hematology.

[29]  I. Jacobs,et al.  Molecular quantification and mapping of lymph-node micrometastases in cervical cancer , 2001, The Lancet.

[30]  F. Marincola,et al.  A natural history of melanoma: serial gene expression analysis. , 2000, Immunology today.

[31]  J. Eshleman,et al.  Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. , 2000, The Journal of molecular diagnostics : JMD.

[32]  J W Gray,et al.  An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. , 2000, Cancer research.

[33]  T. Godfrey,et al.  Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. , 2000, Cancer research.

[34]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[35]  F. Marincola,et al.  Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination. , 2000, Journal of the National Cancer Institute.

[36]  F. Marincola,et al.  Status of Activation of Circulating Vaccine-Elicited CD8+ T Cells , 2000, The Journal of Immunology.

[37]  C. V. D. Schoot,et al.  Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia , 2000, Leukemia.

[38]  A. Elmaagacli,et al.  The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage , 2000, Annals of Hematology.

[39]  H. Vetter,et al.  High Percentage of False-Positive Results of Cytokeratin 19 RT-PCR in Blood: A Model for the Analysis of Illegitimate Gene Expression , 2000, Oncology.

[40]  F. Marincola,et al.  High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.

[41]  R. Cote,et al.  Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer. , 2000, Cancer treatment reviews.

[42]  S. Germer,et al.  High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. , 2000, Genome research.

[43]  A. Ganser,et al.  The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease , 2000, Hematology.

[44]  E. Wang,et al.  Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. , 1999, Journal of immunology.

[45]  L. Medeiros,et al.  Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32). , 1999, American journal of clinical pathology.

[46]  Mario Roederer,et al.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients , 1999, Nature Medicine.

[47]  T. Wobbes,et al.  Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR , 1999, British Journal of Cancer.

[48]  R. Scheuermann,et al.  Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. , 1999, The American journal of pathology.

[49]  N S Williams,et al.  Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients , 1999, British Journal of Cancer.

[50]  M. Caligiuri,et al.  Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay , 1998, Leukemia.

[51]  C. Petropoulos,et al.  Advances in quantitative PCR technology: 5' nuclease assays. , 1998, Current opinion in biotechnology.

[52]  M. Paul,et al.  Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. , 1997, BioTechniques.

[53]  A. Thor,et al.  Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.

[54]  E. Petricoin,et al.  Laser Capture Microdissection , 1996, Science.

[55]  Carissa A. Sanchez,et al.  Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. , 1996, Oncogene.

[56]  A. Borkhardt,et al.  Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. , 1995, Leukemia & lymphoma.

[57]  S Nedjar,et al.  Simultaneous amplification and detection of specific hepatitis B virus and hepatitis C virus genomic sequences in serum samples , 1994, Journal of medical virology.

[58]  C. R. Connell,et al.  Allelic discrimination by nick-translation PCR with fluorogenic probes. , 1993, Nucleic acids research.

[59]  P. Walsh,et al.  Simultaneous Amplification and Detection of Specific DNA Sequences , 1992, Bio/Technology.

[60]  F. Marincola,et al.  The dual role of IL-10. , 2003, Trends in immunology.

[61]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[62]  M. Solanas,et al.  Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors. , 2001, Analytical biochemistry.

[63]  A. Ganser,et al.  The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; Malignancy. , 2001, Hematology.

[64]  J. Reiffers,et al.  Expression of interferon- a (IFN- a ) receptor 2c at diagnosis is associated with cytogenetic response in IFN- a –treated chronic myeloid leukemia , 2001 .

[65]  D. Botstein,et al.  Exploring the new world of the genome with DNA microarrays , 1999, Nature Genetics.

[66]  K. Brown,et al.  Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay. , 1997, Genetic testing.

[67]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.